Cited by 482Pluripotent Stem Cells ResearchAlzheimer's disease research and treatmentsNeurogenesis and neuroplasticity mechanisms

The DOI matches its Crossref record; 234 of the 235 references it cites were found in a registry or an index.

Modeling Alzheimer’s disease with iPSC-derived brain cells

Open access

Penney, Jay, Ralvenius, William T., Tsai, Li-Huei·2020·Molecular Psychiatry

DOI 10.1038/s41380-019-0468-3PMC PMC6906186

Open this paper in CoChat — free account Open PDF

Abstract

Alzheimer's disease is a devastating neurodegenerative disorder with no cure. Countless promising therapeutics have shown efficacy in rodent Alzheimer's disease models yet failed to benefit human patients. While hope remains that earlier intervention with existing therapeutics will improve outcomes, it is becoming increasingly clear that new approaches to understand and combat the pathophysiology of Alzheimer's disease are needed. Human induced pluripotent stem cell (iPSC) technologies have changed the face of preclinical research and iPSC-derived cell types are being utilized to study an array of human conditions, including neurodegenerative disease. All major brain cell types can now be differentiated from iPSCs, while increasingly complex co-culture systems are being developed to facilitate neuroscience research. Many cellular functions perturbed in Alzheimer's disease can be recapitulated using iPSC-derived cells in vitro, and co-culture platforms are beginning to yield insights into the complex interactions that occur between brain cell types during neurodegeneration. Further, iPSC-based systems and genome editing tools will be critical in understanding the roles of the numerous new genes and mutations found to modify Alzheimer's disease risk in the past decade. While still in their relative infancy, these developing iPSC-based technologies hold considerable promise to push forward efforts to combat Alzheimer's disease and other neurodegenerative disorders.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/s41380-019-0468-3

Cites

234 of 234 references verified0 citation errors · 0 not checkable

Statistics

Fig. 1 Brain cell types in Alzheimer’s disease. A summary of the major human brain cell types and the alterations they exhibit in ADCC BY · PubMed Central

Fig. 2 Human iPSC differentiation to brain cell types. Somatic cells from patients or healthy individuals can be reprogrammed to iPSCs and subsequently differentiated into all major brain cell types for in vitro studies. Such studies can examine cellular functions as well as how they are impacted by AD hallmark pathologies or AD-linked mutations. Genome editing techniques can be used to introduce or correct AD-linked mutations to examine phenotypes in isogenic backgrounds. 3D and co-culture models allow for examination of interactions occurring between cell types and sub-types to better model processes occurring in vivo. These and developing techniques hold promise for better understanding the relevant pathomechanisms underlying AD, and will hopefully facilitate development of effective therapeutics to combat dementiaCC BY · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Neurotoxic reactive astrocytes are induced by activated microglia
Liddelow, S. A., Guttenplan, K. A., Clarke, L. E., Bennett, F. C., Bohlen, C. J., Schirmer, L., Bennett, M. L., Münch, A. E., Chung, W.-S., Peterson, T. C., et al. (2017) · Nature · doi:10.1038/nature21029 · Cited by 7,971
Alzheimer's disease: the amyloid cascade hypothesis
Hardy, J. A., & Higgins, G. A. (1992) · Science · doi:10.1126/science.1566067 · Cited by 7,484
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372
Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease
Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336
Hearing loss and cognitive decline in older adults
Lin, F. R., Yaffe, K., Xia, J., Xue, Q.-L., Harris, T. B., Purchase-Helzner, E., Satterfield, S., Ayonayon, H. N., Ferrucci, L., Simonsick, E. M., et al. (2013) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2013.1868 · Cited by 4,017

Show all 235 references

Sorted by citations

Items 201–300 of 482

Neuroprotective mechanism of trans,trans-Farnesol in an ICV-STZ-induced rat model of Alzheimer’s pathology
Kadian, M., Saini, N., Khera, A., & Kumar, A. (2024) · Inflammopharmacology · doi:10.1007/s10787-023-01413-8 · Cited by 12
Multimodal beneficial effects of BNN27, a nerve growth factor synthetic mimetic, in the 5xFAD mouse model of Alzheimer’s disease
Kokkali, M., Karali, K., Thanou, E., Παπαδοπούλου, Μ., Zota, I., Tsimpolis, A., Efstathopoulos, P., Calogeropoulou, T., Li, K. W., Sidiropoulou, K., et al. (2024) · Molecular Psychiatry · doi:10.1038/s41380-024-02833-w · Cited by 13
Stem Cell-Based Approaches for Spinal Cord Injury: The Promise of iPSCs
Zeng, C. (2025) · Biology · doi:10.3390/biology14030314 · Cited by 14
Exploring links between 2‐oxoglutarate‐dependent oxygenases and Alzheimer's disease
Liu, H., Xie, Y., Wang, X., Abboud, M. I., Ma, C., Ge, W., & Schofield, C. J. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12733 · Cited by 14
Evaluating Translational Methods for Personalized Medicine—A Scoping Review
Fosse, V., Oldoni, E., Gerardi, C., Banzi, R., Fratelli, M., Biétrix, F., Ussi, A. E., Andreu, A. L., McCormack, E., & the PERMIT Group (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12071177 · Cited by 14
Matrix Metalloproteinase 14 Mediates APP Proteolysis and Lysosomal Alterations Induced by Oxidative Stress in Human Neuronal Cells
Llorente, P., Martins, S., Sastre, I., Aldudo, J., Recuero, M., Adjaye, J., & Bullido, M. J. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/5917187 · Cited by 10
REMOVED: Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide
Sharma, H. S., Muresanu, D. F., Nozari, A., Lafuente, J. V., Buzoianu, A. D., Sahib, S., Tian, Z. R., Bryukhovetskiy, I., Manzhulo, I., Menon, P. K., et al. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.04.008 · Cited by 11
Mass Spectrometry Imaging Reveals Early Metabolic Priming of Cell Lineage in Differentiating Human-Induced Pluripotent Stem Cells
Nikitina, A. A., Grouw, A. V., Roysam, T., Huang, D., Fernández, F. M., & Kemp, M. L. (2023) · Analytical Chemistry · doi:10.1021/acs.analchem.2c04416 · Cited by 11
PSEN1 E280A Cholinergic-like Neurons and Cerebral Spheroids Derived from Mesenchymal Stromal Cells and from Induced Pluripotent Stem Cells Are Neuropathologically Equivalent
Mendivil‐Perez, M., Velez‐Pardo, C., Lopera, F. J., Kosik, K. S., & Jiménez-Del-Río, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108957 · Cited by 10
Generation of Human Neurons and Oligodendrocytes from Pluripotent Stem Cells for Modeling Neuron-Oligodendrocyte Interactions
Assetta, B., Tang, C., Bian, J., O'Rourke, R., Connolly, K., Brickler, T., Chetty, S., & Huang, Y.-W. A. (2020) · Journal of Visualized Experiments · doi:10.3791/61778 · Cited by 11
Investigation on Electrospun and Solvent-Casted PCL-PLGA Blends Scaffolds Embedded with Induced Pluripotent Stem Cells for Tissue Engineering
Rosalia, M., Giacomini, M., Tottoli, E. M., Dorati, R., Bruni, G., Genta, I., Chiesa, E., Pisani, S., Sampaolesi, M., & Conti, B. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15122736 · Cited by 10
Bridging Retinal and Cerebral Neurodegeneration: A Focus on Crosslinks between Alzheimer–Perusini’s Disease and Retinal Dystrophies
Donato, L., Mordà, D., Scimone, C., Alibrandi, S., D’Angelo, R., & Sidoti, A. (2023) · Biomedicines · doi:10.3390/biomedicines11123258 · Cited by 12
A human neuron Alzheimer’s disease model reveals barriers to senolytic translatability
Walton, C. C., Wang, E. Y., Lee, S., Siebrand, C. J., Bergo, N. J., Mayeri, Z., & Andersen, J. K. (2025) · Alzheimer s Research & Therapy · doi:10.1186/s13195-025-01822-7 · Cited by 10
Application of Induced Pluripotent Stem Cells for Disease Modeling and 3D Model Construction: Focus on Osteoarthritis
Hwang, J. J., Choi, J., Rim, Y. A., Nam, Y., & Ju, J. H. (2021) · Cells · doi:10.3390/cells10113032 · Cited by 10
The PSEN1 E280G mutation leads to increased amyloid-β43 production in induced pluripotent stem cell neurons and deposition in brain tissue
Willumsen, N., Arber, C., Lovejoy, C. E. J., Toombs, J., Alatza, A., Weston, P. S. J., Chávez‐Gutiérrez, L., Hardy, J., Zetterberg, H., Fox, N. C., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac321 · Cited by 10
Novel Development and Prospects in Pathogenesis, Diagnosis, and Therapy of Alzheimer’s Disease
Teng, Z. (2024) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-230130 · Cited by 10
The Potential Use of Sialic Acid From Edible Bird’s Nest to Attenuate Mitochondrial Dysfunction by In Vitro Study
Rashed, A. A., Ahmad, H., Khalid, S. K. A., & Rathi, D.-N. G. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.633303 · Cited by 10
Unraveling pathological mechanisms in neurological disorders: the impact of cell-based and organoid models
Langlie, J. A., Mittal, R., Finberg, A., Bencie, N. B., Mittal, J., Omidian, H., Omidi, Y., & Eshraghi, A. A. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335836 · Cited by 10
The coherence between PSMC6 and α-ring in the 26S proteasome is associated with Alzheimer’s disease
Xiong, J., Pang, X., Song, X., Yang, L., & Pang, C.-Y. (2024) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1330853 · Cited by 11
Lipid–polymer hybrid nanoparticles loaded with N -acetylcysteine for the modulation of neuroinflammatory biomarkers in human iPSC-derived PSEN2 (N141I) astrocytes as a model of Alzheimer's disease
Vargas-Barona, A., Bernáldez-Sarabia, J., & Castro-Ceseña, A. B. (2024) · Journal of Materials Chemistry B · doi:10.1039/d4tb00521j · Cited by 10
Drug Delivery Targeting Neuroinflammation to Treat Brain Diseases
Wang, J., Jia, R., Wan, W., Han, H., Wang, G., Li, Z., & Li, J. (2024) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.4c00414 · Cited by 9
Neuroprotective Effects of Hesperidin and CK2 Inhibitor DRB on Aβ1-42-Induced Neurotoxicity in Differentiated SH-SY5Y Cells
Eciroglu, H., Çelik, P. A., Kelicen‐Uğur, P., & Dönmez‐Altuntaş, H. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05082-2 · Cited by 9
Human brain organoids: an innovative model for neurological disorder research and therapy
Li, H., Zhu, J., Li, J., Wu, Y., Luo, C., Huang, Y., Wu, J., Liu, W., Wang, H., & Mo, Z. (2025) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2025.1658074 · Cited by 11
CRISPR/cas genome editing for neurodegenerative diseases: Mechanisms, therapeutic advances, and clinical prospects
Pandya, K., & Kumar, D. (2025) · Ageing Research Reviews · doi:10.1016/j.arr.2025.102922 · Cited by 9
Human-Induced Pluripotent Stem Cell–Based Models for Studying Sex-Specific Differences in Neurodegenerative Diseases
Kiris, E. (2021) · Advances in experimental medicine and biology · doi:10.1007/5584_2021_683 · Cited by 9
Perspectives on Mechanisms Supporting Neuronal Polarity From Small Animals to Humans
Wilson, C., Moyano, A. L., & Cáceres, A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.878142 · Cited by 9
Building in vitro models of the brain to understand the role ofAPOEin Alzheimer’s disease
Pinals, R. L., & Tsai, L. (2022) · Life Science Alliance · doi:10.26508/lsa.202201542 · Cited by 10
Self-citation
Proteomic analysis across patient iPSC-based models and human post-mortem hippocampal tissue reveals early cellular dysfunction and progression of Alzheimer’s disease pathogenesis
Pomeshchik, Y., Velásquez, E., Gil, J., Klementieva, O. L., Gidlöf, R., Sydoff, M., Bagnoli, S., Nacmias, B., Sorbi, S., Westergren‐Thorsson, G., et al. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01649-z · Cited by 10
A Combination of Heavy Metals and Intracellular Pathway Modulators Induces Alzheimer Disease-like Pathologies in Organotypic Brain Slices
Korde, D. S., & Humpel, C. (2024) · Biomolecules · doi:10.3390/biom14020165 · Cited by 9
Using iPSC Models to Understand the Role of Estrogen in Neuron–Glia Interactions in Schizophrenia and Bipolar Disorder
de Assis, D. R., Szabó, A., Osete, J. R., Puppo, F., O’Connell, K. S., Akkouh, I. A., Hughes, T., Frei, E., Andreassen, O. A., & Djurovic, S. (2021) · Cells · doi:10.3390/cells10020209 · Cited by 10
Modeling and Targeting Neuroglial Interactions with Human Pluripotent Stem Cell Models
Bigarreau, J., Rouach, N., Perrier, A. L., Mouthon, F., & Charvériat, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031684 · Cited by 10
Proteome architecture of human-induced pluripotent stem cell-derived three-dimensional organoids as a tool for early diagnosis of neuronal disorders
Negi, R., Srivastava, A. K., Srivastava, A. K., Pandeya, A., Vatsa, P., Ansari, U. A., & Pant, A. B. (2023) · Indian Journal of Pharmacology · doi:10.4103/ijp.ijp_56_23 · Cited by 9
A multi-looping chromatin signature predicts dysregulated gene expression in neurons with familial Alzheimer’s disease mutationsPreprint
Chandrashekar, H., Simándi, Z., Choi, H., Ryu, H.-S., Waldman, A. J., Nikish, A., Muppidi, S. S., Gong, W., Paquet, D., & Phillips‐Cremins, J. E. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.02.27.582395 · Cited by 10
Research on Alzheimer's Disease (AD) Involving the Use of In vivo and In vitro Models and Mechanisms
Sinha, S., Wal, P., Prakash Goudanavar, S. O. P., Divya, S., Kimothi, V., Jyothi, D., Sharma, M. C., & Wal, A. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249293642240522054929 · Cited by 9
A neuroimmune cerebral assembloid model to study the pathophysiology of familial Alzheimer’s disease
Becerra-Calixto, A., Banerjee, A., Fan, H., Tan, C., Lee, E., McCullough, L. D., & Lee, J. (2025) · Journal of Neuroinflammation · doi:10.1186/s12974-025-03544-x · Cited by 10
Repurposing oncology drugs for Alzheimer’s: multi-omic convergence targeting cell-cycle, proteostasis, immunometabolism, and senescence
Gopukumar, S. T., Dwivedi, D., Gowri, K., Karpakavalli, M., Nair, C., Singh, D., & Das, U. (2025) · Medicine in Drug Discovery · doi:10.1016/j.medidd.2025.100237 · Cited by 11
Development of an accelerated cellular model for early changes in Alzheimer’s disease
Xue, H., Gate, S., Gentry, E., Losert, W., & Cao, K. (2023) · Scientific Reports · doi:10.1038/s41598-023-45826-5 · Cited by 8
On‐Chip Neural Induction Boosts Neural Stem Cell Commitment: Toward a Pipeline for iPSC‐Based Therapies
Jain, S., Voulgaris, D., Thongkorn, S., Hesen, R., Hägg, A., Moslem, M., Falk, A., & Herland, A. (2024) · Advanced Science · doi:10.1002/advs.202401859 · Cited by 8
Discovery platforms for RNA therapeutics
Ciucci, G., Braga, L., & Zacchigna, S. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16424 · Cited by 8
Age-Related Neurodegenerative Diseases: A Stem Cell’s Perspective
Calvo, B., Schembri-Wismayer, P., & Alonso, M. B. D. (2025) · Cells · doi:10.3390/cells14050347 · Cited by 9
Deficiency in MT5-MMP Supports Branching of Human iPSCs-Derived Neurons and Reduces Expression of GLAST/S100 in iPSCs-Derived Astrocytes
Arnst, N., Mairal, P. B., García‐González, L., Arnaud, L., Greetham, L., Nivet, E., Rivera, S., & Dityatev, A. E. (2021) · Cells · doi:10.3390/cells10071705 · Cited by 8
Upregulated extracellular matrix-related genes and impaired synaptic activity in dopaminergic and hippocampal neurons derived from Parkinson’s disease patients with PINK1 and PARK2 mutationsPreprint
Tripathi, U., Rosh, I., Ezer, R. B., Nayak, R., Choudhary, A., Djamus, J., Manole, A., Haulden, H., Gage, F. H., & Stern, S. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.12.09.519781 · Cited by 8
Dynamic neuroinflammatory profiles predict Alzheimer’s disease pathology in microglia-containing cerebral organoidsPreprint
Kuhn, M. K., Kang, R. Y., Kim, C., Tagay, Y., Morris, N., Tabdanov, E. D., Elcheva, I. A., & Proctor, E. A. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.16.567220 · Cited by 9
Allele-specific transcription factor binding across human brain regions offers mechanistic insight into eQTLsPreprint
Anderson, A. G., Moyers, B. A., Loupe, J. M., Rodríguez-Nunez, I., Felker, S. A., Lawlor, J. M. J., Bunney, W. E., Bunney, B. G., Cartagena, P. M., Sequeira, A., et al. (2024) · Genome Research · doi:10.1101/gr.278601.123 · Cited by 7
Modeling common Alzheimer’s disease with high and low polygenic risk in human iPSC: A large-scale research resource
Maguire, E., Winston, J., Ellwood, S. H., O’Donoghue, R., Shaw, B., Castillo-Morales, A., Keat, S., Evans, A., Marshall, I. J., Luckcuck, L., et al. (2025) · Stem Cell Reports · doi:10.1016/j.stemcr.2025.102570 · Cited by 7
Microphysiological models of the central nervous system with fluid flow
Zilberman, A., & Cornelison, R. C. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.05.015 · Cited by 7
Advances in iPSC Technology in Neural Disease Modeling, Drug Screening, and Therapy
Dai, S., Qiu, L., Veeraraghavan, V. P., Sheu, C., & Mony, U. (2023) · Current Stem Cell Research & Therapy · doi:10.2174/1574888x18666230608105703 · Cited by 8
Explainable Alzheimer’s Disease Detection Using Linguistic Features from Automatic Speech Recognition
Tang, L., Zhang, Z., Feng, F., Yang, L., & Li, H. H. (2023) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000531818 · Cited by 9
Shaping early neural development by timed elevated tissue oxygen tension: Insights from multiomic analysis on human cerebral organoids
Liu, Y., Chung, M. T., Lin, H., Lee, T., Cheng, Y.-J., Huang, C., Wu, H., & Tung, Y. (2025) · Science Advances · doi:10.1126/sciadv.ado1164 · Cited by 7
Use of AD Informer Set compounds to explore validity of novel targets in Alzheimer's disease pathology
Potjewyd, F., Annor‐Gyamfi, J. K., Aubé, J., Chu, S., Conlon, I. L., Frankowski, K. J., Guduru, S. K. R., Hardy, B. P., Hopkins, M. D., Kinoshita, C., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12253 · Cited by 8
CLARITY increases sensitivity and specificity of fluorescence immunostaining in long-term archived human brain tissuePreprint
Woelfle, S., Deshpande, D., Feldengut, S., Roselli, F., Deisseroth, K. A., Michaelis, J., Boeckers, T. M., & Schön, M. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.27.489700 · Cited by 7
APOE3 Christchurch modulates tau phosphorylation and β-catenin/Wnt/Cadherin signaling in induced pluripotent stem cell-derived cerebral organoids from Alzheimer’s casesPreprint
Mazzarino, R. C., Perez-Corredor, P. A., Vanderleest, T. E., Vacano, G. N., Sanchez, J. S., Villalba‐Moreno, N. D., Krausemann, S., Mendivil-Perez, M., Aguillon, D. F., Jiménez-Del-Río, M., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.11.523290 · Cited by 7
Organelle perturbation in Alzheimer’s disease: do intracellular amyloid-ß and the fragmented Golgi mediate early intracellular neurotoxicity?
Fourrière, L., & Gleeson, P. A. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1550211 · Cited by 6
Overexpression of LINC00672 promotes autophagy in Alzheimer’s disease by upregulating GPNMB
Gao, L., Hu, S., Lv, Y., Zheng, G., & Lin, Z. (2025) · PLoS ONE · doi:10.1371/journal.pone.0322708 · Cited by 6
An Alzheimer’s disease-associated common regulatory variant in a PTK2B intron alters microglial function
Bello, E., Long, K. R., Iwama, S., Steer, J., Cooper, S., Alasoo, K., Kumasaka, N., Schwartzentruber, J., Panousis, N. I., & Bassett, A. R. (2026) · iScience · doi:10.1016/j.isci.2026.115688 · Cited by 7
In and out: Benchmarking in vitro, in vivo, ex vivo, and xenografting approaches for an integrative brain disease modeling pipeline
Pereira, M. F., Shyti, R., & Testa, G. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.05.004 · Cited by 8
Modeling and correction of protein conformational disease in iPSC-derived neurons through personalized base editing
Konishi, C. T., Mulaiese, N., Butola, T., Zhang, Q., Kagan, D., Yang, Q., Pressler, M., Dirvin, B. G., Devinsky, O., Basu, J., et al. (2024) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2024.102441 · Cited by 6
Functional genomics, genetic risk profiling and cell phenotypes in neurodegenerative disease
Finkbeiner, S. M. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105088 · Cited by 8
Human Dental Pulp Stem Cells Display a Potential for Modeling Alzheimer Disease-Related Tau Modifications
Gazarian, K. G., Ramírez-García, L. R., Orozco, L. T., Luna‐Muñoz, J., & Pacheco‐Herrero, M. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2020.612657 · Cited by 6
Stem Cell Therapy for Neuroprotection in the Growth-Restricted Newborn
Chand, K. K., Nano, R., Wixey, J. A., & Patel, J. (2022) · Stem Cells Translational Medicine · doi:10.1093/stcltm/szac005 · Cited by 5
Disease Modeling of Neurodegenerative Disorders Using Direct Neural Reprogramming
Legault, E. M., Bouquety, J., & Drouin‐Ouellet, J. (2022) · Cellular Reprogramming · doi:10.1089/cell.2021.0172 · Cited by 7
The Neuroepigenetic Landscape of Vertebrate and Invertebrate Models of Neurodegenerative Diseases
Sundaramoorthy, T. H., & Castanho, I. (2022) · Epigenetics Insights · doi:10.1177/25168657221135848 · Cited by 6
Alzheimer’s Disease: Understanding Its Novel Drug Delivery Systems and Treatments
Dhingra, H., & Choudhari, S. G. (2022) · Cureus · doi:10.7759/cureus.31394 · Cited by 9
Generation of an Open-Access Patient-Derived iPSC Biobank for Amyotrophic Lateral Sclerosis Disease Modelling
Hedges, E. C., Cocks, G. D., Shaw, C. E., & Nishimura, A. L. (2023) · Genes · doi:10.3390/genes14051108 · Cited by 6
The Potential of Induced Pluripotent Stem Cells to Treat and Model Alzheimer’s Disease
Schulz, J. M. (2021) · Stem Cells International · doi:10.1155/2021/5511630 · Cited by 6
AD Informer Set: Chemical tools to facilitate Alzheimer's disease drug discovery
Potjewyd, F., Annor‐Gyamfi, J. K., Aubé, J., Chu, S., Conlon, I. L., Frankowski, K. J., Guduru, S. K. R., Hardy, B. P., Hopkins, M. D., Kinoshita, C., et al. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12246 · Cited by 6
Stem cell therapy offers new hope for the treatment of Alzheimer’s disease
He, G., Huang, J., Zeng, Z., Sun, H., Wu, C., Xu, Q., Hu, C., Jin, B., Tong, M., & Wang, C. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1650885 · Cited by 7
Integration without integrated models or theories
Hochstein, E. (2023) · Synthese · doi:10.1007/s11229-023-04298-w · Cited by 5
Functional characterization of a single nucleotide polymorphism associated with Alzheimer’s disease in a hiPSC-based neuron model
Stolzenburg, L. R., Esmaeeli, S., Kulkarni, A. S., Murphy, E., Kwon, T., Preiss, C. N., Bahnassawy, L., Stender, J. D., Manos, J. D., Reinhardt, P., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0291029 · Cited by 5
Microglial Drivers of Alzheimer's Disease Pathology: An Evolution of Diverse Participating States
Kuhn, M. K., & Proctor, E. A. (2024) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.26723 · Cited by 5
From Better Diagnostics to Earlier Treatment: The Rapidly Evolving Alzheimer’s Disease Landscape
Bougea, A. M., Debasa‐Mouce, M., Gulkarov, S., Castro‐Mosquera, M., Reiss, A. B., & Ouro, A. (2025) · Medicina · doi:10.3390/medicina61081462 · Cited by 5
Modelling sex differences of neurological disorders in vitro
Castro‐Aldrete, L., Einsiedler, M., Cuní‐López, C., Vanhaelen, Q., Silvestri, A., Ferretti, M. T., de Gennaro, M. E., Putignano, G., Guix, M., Marino, N., et al. (2025) · Nature Reviews Bioengineering · doi:10.1038/s44222-025-00355-w · Cited by 4
The role for artificial intelligence in identifying combination therapies for Alzheimer’s disease
Cheng, F., Sha, Z., Zhou, Y., Hou, Y., Zhang, P., Pieper, A. A., & Cummings, J. L. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100366 · Cited by 6
Potential role of recombinant growth differentiation factor 11 in Alzheimer’s disease treatment
de Liyis, B. G., Halim, W., & Widyadharma, I. P. E. (2022) · The Egyptian Journal of Neurology Psychiatry and Neurosurgery · doi:10.1186/s41983-022-00487-5 · Cited by 5
Assessing the neurotoxicity of airborne nano-scale particulate matter in human iPSC-derived neurons using a transcriptomics benchmark dose model
Zhang, Z., Li, X., Jiang, S., Qiu, C., Guo, P., Wang, Z., Xu, C., Zhang, L., Ma, X., Chen, S., et al. (2022) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2022.116109 · Cited by 5
A fully automated primary neuron purification system using continuous centrifugal microfluidics
Intisar, A., Lee, S. J., Kim, Y., Kim, W., Shin, H. Y., Kim, M. Y., Kim, J. M., Lee, J.-M., Mo, Y. J., Kim, Y. S., et al. (2022) · Lab on a Chip · doi:10.1039/d2lc00381c · Cited by 5
Bone Marrow-Derived Mesenchymal Stem Cells and γ-Secretase Inhibitor Treatments Suppress Amyloid-β25–35-Induced Cognitive Impairment in Rat Dams and Cortical Degeneration in Offspring
Gaber, A. M., El-Bakry, A. M., Aljàrari, R. M., Jaber, F. A., Khadrawy, Y. A., Sabry, D., Abo‐Eleneen, R. E., & Ahmed, O. M. (2023) · Stem Cells International · doi:10.1155/2023/2690949 · Cited by 5
Morphological Changes in Neural Progenitors Derived from Human Induced Pluripotent Stem Cells and Transplanted into the Striatum of a Parkinson's Disease Rat Model
Воронков, Д. Н., Stavrovskaya, A. V., Lebedeva, O. S., Li, W., Olshansky, A. S., Гущина, А. С., Рафаилевна, К. М., Bogomazova, A. N., Lagarkova, M. A., & Illarioshkin, S. N. (2023) · Annals of Clinical and Experimental Neurology · doi:10.54101/acen.2023.2.6 · Cited by 5
N -Glycan profile of the cell membrane as a probe for lipopolysaccharide-induced microglial neuroinflammation uncovers the effects of common fatty acid supplementation
Grijaldo-Alvarez, S. J. B., Alvarez, M. R., Schindler, R. L., Oloumi, A., Hernandez, N., Seales, T., Angeles, J. G. C., Nacario, R. C., Completo, G. C. J., Zivkovic, A. M., et al. (2024) · Food & Function · doi:10.1039/d4fo01598c · Cited by 5
Smart Polymeric 3D Microscaffolds Hosting Spheroids for Neuronal Research via Quantum Metrology
Costa, B. N. L., Marote, A., Barbosa, C. S., Campos, J., Salgado, A. J., & Nieder, J. B. (2025) · Advanced Healthcare Materials · doi:10.1002/adhm.202403875 · Cited by 8
Distribution of Particles in Human Stem Cell-Derived 3D Neuronal Cell Models: Effect of Particle Size, Charge, and Density
Czuba‐Wojnilowicz, E., Miellet, S., Glab, A., Viventi, S., Cavalieri, F., Cortez‐Jugo, C., Dottori, M., & Caruso, F. (2020) · Biomacromolecules · doi:10.1021/acs.biomac.0c00626 · Cited by 5
Direct conversion of fibroblast into neurons for Alzheimer's disease research: a systematic review
Sattarov, R., Toresson, H., Orbjörn, C., & Mattsson-Carlgren, N. (2023) · Journal of Alzheimer’s Disease · doi:10.3233/jad-230119 · Cited by 4
Induced Pluripotent Stem Cells (iPSC) and Their Use in Disease Modeling
Dorota, A., Maryniak, N., Mariankowska, A., Milczarek, C., Dorota, M., Żywiec, W., Kozlowski, K., Koval, I., Czyżewski, B. M., & Czyzewska, J. (2025) · Cureus · doi:10.7759/cureus.93999 · Cited by 4
Comparative neurotoxicity of Bisphenol-A and aluminum chloride in adult zebrafish: Behavioral disruption and region-specific neuropathology under chronic exposure
Logeshwari, B., Jeyabalan, S., Veeraraghavan, G., Krishnaraj, K., Ashok, C., Rajasekaran, N. K., Wong, L. S., Subramaniyan, V., & Sekar, M. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.102161 · Cited by 4
Assessment and Evaluation of Contemporary Approaches for Astrocyte Differentiation from hiPSCs: A Modeling Paradigm for Alzheimer's Disease
Juráková, V., Széky, B., Zapletalová, M., Fehér, A., Zana, M., Pandey, S., Kučera, R., Šerý, O., Hudeček, J., Dinnyés, A., et al. (2024) · Biological Procedures Online · doi:10.1186/s12575-024-00257-y · Cited by 4
The Therapeutic Potential of ADSC-Secreted LEFTY2 in Treating Alzheimer’s Disease
Wuli, W., Yang, H., Chiou, T., Woon, P. Y., Xu, Y., Tjandra, C., Wijaya, I., Harn, H., & Lin, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073382 · Cited by 4
Epigenetic Insights into Vascular Cognitive Impairment: DNA Methylation in the Human Brain Tissue
Vishweswaraiah, S., Saiyed, N., Khalid, A., Milčiūtė, M., Gabrielaitė, M., Buyuker, C., Aksakal, B., Gomes, L., Gordevičius, J., Yılmaz, A., et al. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-05119-6 · Cited by 4
Lineage specification into GABAergic, glutamatergic, dopaminergic, and astrocytic phenotypes using MUSE stem cells: a novel approach for modeling neurodegenerative and psychiatric disorders
Aprile, D., Patrone, D., Sammarraie, S. H. A. A., Alessio, N., Peluso, G., Bernardo, G. D., & Galderisi, U. (2025) · Molecular Psychiatry · doi:10.1038/s41380-025-03251-2 · Cited by 4
Modeling neurovascular dysfunction in Alzheimer’s disease using an isogenic brain-chip model
Shen, A. N., Matazel, K. S., Gill, W. D., Ewart, L. C., Daughters, R. S., & Rosas-Hernández, H. (2026) · Fluids and Barriers of the CNS · doi:10.1186/s12987-025-00708-y · Cited by 5
Apolipoprotein E2 Expression Alters Endosomal Pathways in a Mouse Model With Increased Brain Exosome Levels During Aging
Peng, K. Y., Liemisa, B., Pasato, J., D’Acunzo, P., Pawlik, M., Heguy, A., Penikalapati, S. C., Labuza, A., Pidikiti, H., Alldred, M. J., et al. (2024) · Traffic · doi:10.1111/tra.12937 · Cited by 4
A Novel Recombinant Vitronectin Variant Supports the Expansion and Differentiation of Pluripotent Stem Cells in Defined Animal-Free Workflows
Lu, X., Perr, E., Naqvi, T., Galitz, D., Andersen, M., Grabowski, D. C., Person, A. D., Kalyuzhny, A. E., & Flynn, K. C. (2024) · Cells · doi:10.3390/cells13181566 · Cited by 4
Unique N-glycosylation signatures in human iPSC derived microglia activated by Aβ oligomer and lipopolysaccharide
Tang, X., Schindler, R. L., Lucente, J. D., Oloumi, A., Tena, J., Harvey, D. J., Lebrilla, C. B., Zivkovic, A. M., Jin, L., & Maezawa, I. (2025) · Scientific Reports · doi:10.1038/s41598-025-96596-1 · Cited by 6
A Quantitative Proteomic Approach Explores the Possible Mechanisms by Which the Small Molecule Stemazole Promotes the Survival of Human Neural Stem Cells
Chen, M., Zhu, Y., Li, H., Zhang, Y., & Han, M. (2022) · Brain Sciences · doi:10.3390/brainsci12060690 · Cited by 4
Challenges and opportunities for discovering the biology of rare genetic diseases of the brain
Raghu, P., Sharma, Y., Devi, A. B. N. S., & Krishnan, H. (2024) · Journal of Biosciences · doi:10.1007/s12038-023-00408-5 · Cited by 4
Multiscale Microstructure for Investigation of Cell–Cell Communication
Schneider, A., Scharnweber, T., Cammann, D., Rapp, B. E., Giselbrecht, S., & Niemeyer, C. M. (2020) · Small Methods · doi:10.1002/smtd.202000647 · Cited by 4
Microfluidic chip for label-free removal of teratoma-forming cells from therapeutic human stem cells
Wellmerling, K., Lehmann, C., Singh, A. K., & Kirby, B. J. (2020) · Journal of Immunology and Regenerative Medicine · doi:10.1016/j.regen.2020.100030 · Cited by 4
3D models of Alzheimer’s disease patient microglia recapitulate disease phenotype and show differential drug responses compared to 2DPreprint
Cuní‐López, C., Quek, H., Oikari, L. E., Stewart, R., Nguyen, T. H., Sun, Y., Guo, C. C., Lupton, M. K., & White, A. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.17.435758 · Cited by 4
Elevated p16Ink4a Expression Enhances Tau Phosphorylation in Neurons Differentiated From Human‐Induced Pluripotent Stem Cells
Holloway, K., Neherin, K., Song, Y., Sato, K., Houston, A., Chen, F., Li, D., & Zhang, H. (2025) · Aging Cell · doi:10.1111/acel.14472 · Cited by 3
The Fate and Dynamics of Neural Stem Cells (NSCs) and Their Neurogenic Decline in Alzheimer’s Disease
Naffaa, M. M. (2025) · Lifespan development and mental health. · doi:10.70322/ldmh.2025.10005 · Cited by 3
Targeted Delivery Modalities in Combination with Biofunctionalized Metallic Nanoparticles (MNPs): Combating Amyloid Plaques
Kushwaha, N., Panjwani, D., Akarte, K., Patel, S., Ahlawat, P., Kesarla, R., Yadav, M. R., & Patel, A. (2025) · Current Nanoscience · doi:10.2174/0115734137361817250325071654 · Cited by 3

Authors: Penney, J., Ralvenius, W. T., & Tsai, L.-H.
Affiliations: Massachusetts Institute of Technology (US)
Corresponding author: Tsai, Li-Huei
ORCID: Penney, Jay
Ralvenius, William T.
Tsai, Li-Huei
Venue: Molecular Psychiatry
Publisher: Springer Science and Business Media LLC
Published: 2019-08-07
Volume: 25
Issue: 1
Pages: 148-167
ISSN: 1359-4184 (ISSN-L)
1476-5578
DOI: 10.1038/s41380-019-0468-3
PMC: PMC6906186
OpenAlex: W2964627277
Cited by: 471
References: 235
Citations by year: 2026: 54 · 2025: 66 · 2024: 78 · 2023: 84 · 2022: 77 · 2021: 65 · 2020: 41 · 2019: 6
FWCI: 4.18
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
creativecommons.org/licenses/by/4.0 (tdm)
creativecommons.org/licenses/by/4.0 (vor)
Locations: Molecular Psychiatry (publishedVersion, cc-by)
PubMed Central (publishedVersion, cc-by)
PubMed (publishedVersion)
DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
IslandScholar (University of Prince Edward Island) (submittedVersion)
Funders: National Science Foundation
Cure Alzheimer's Fund
Robert A. and Renee E. Belfer Family Foundation
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (177920)
National Institutes of Health (NS051874)
National Institute on Aging (RF1AG054012)
National Institute of Neurological Disorders and Stroke (R37NS051874)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords: Alzheimer's disease, induced pluripotent stem cells, neurodegeneration, co-culture model, disease modeling, genome editing, Alzheimer's disease risk genes, preclinical research
MeSH terms: Alzheimer Disease, Brain, Cell Differentiation, Humans, Models, Biological, Neurons, Neurodegenerative Diseases, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Modeling Alzheimer’s disease with iPSC-derived brain cells

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks